L26/P-249 Overcoming Recurrent Fertilization Failure in Complete Globozoospermia: First Ongoing Pregnancy Using the ICSI SPARK Protocol
Human Reproduction · 01.07.2026 · 41 (Supplement_1)
DOI: 10.1093/humrep/deag083.585 ↗Kurz gefasst
Studienprotokoll in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von H. Ruso und 11 weiteren Autor:innen.
Abstract (Originalsprache)
Study question Can a novel ICSI protocol (ICSI SPARK) involving modified sperm deposition and double artificial oocyte activation (AOA) overcome total fertilization failure (TFF) in complete globozoospermia? Summary answer ICSI SPARK enabled the first global ongoing clinical pregnancy in a patient with 100% globozoospermia after repeated failed conventional ICSI and single-AOA cycles. What is known already Complete globozoospermia is a rare, severe form of male-factor infertility characterised by round-headed sperm lacking an acrosome. Because these spermatozoa fail to release the necessary oocyte-activating factors (e.g., PLC-zeta), fertilisation rates with conventional ICSI are near zero. Even with standard artificial oocyte activation (AOA) using calcium ionophores, prognosis remains poor for many patients. Consequently, these couples are often directed toward sperm donation. While AOA has shown some success in similar pathologies, a reliable protocol for consistent blastulation and clinical pregnancy in refractory globozoospermia cases has yet to be established globally. Study design, size, duration This is a clinical case study of a couple with a history of recurrent total fertilisation failure (TFF) across two different UK clinics. The study tracks the transition from conventional ICSI and single-chemical AOA (Cycles 1 and 2) to the implementation of the ICSI SPARK protocol (Cycle 3) in a private fertility setting, resulting in the first reported ongoing viable pregnancy. Participants/materials, setting, methods A patient with 100% globozoospermia underwent Cycle 3 using ICSI SPARK. This protocol involves: 1) Modified mechanical injection where spermatozoa are aspirated close to the oolemma and deposited centrally; 2) Double AOA using Gynemed calcium ionophore to provide dual chemical triggers. This combined approach targets both mechanical and chemical activation pathways. Outcomes were compared against his previous conventional and single-AOA ICSI cycles. Main results and the role of chance Cycle 1 (Conventional ICSI): 15 oocytes retrieved; 0% fertilization. Cycle 2 (Single AOA): 19 oocytes retrieved; 0% fertilization. Cycle 3 (ICSI SPARK): 9 mature oocytes underwent the protocol. No oocytes degenerated. Normal fertilization was achieved in 5/9 oocytes (55.5%), yielding 3 high-quality Day 5 blastocysts. All blastocysts were assessed via morphokinetics and AI grading; 2 were confirmed euploid via PGT-A. The first frozen embryo transfer (FET) resulted in a biochemical pregnancy. The second FET resulted in a clinical pregnancy. At the time of reporting, the pregnancy is at 15 weeks gestation with a normal NIPT result and no complications. Given the 0% fertilization rate in previouslarge-scale attempts (34 total oocytes), the successful fertilization and subsequent pregnancy following ICSI SPARK are highly unlikely to be due to chance and suggest a direct therapeutic effect of the modified activation protocol. Limitations, reasons for caution As this is a single case study, further large-scale prospective trials are required to validate the efficacy of ICSI SPARK across broader populations of patients with oocyte activation deficiencies. While the results are promising, the success may also depend on specific underlying genetic factors in the patient. Wider implications of the findings ICSI SPARK offers a transformative alternative for patients with the most severe male-factor infertility. By successfully bypassing the fertilization barrier in refractory globozoospermia, this protocol may eliminate the need for sperm donation in cases previously considered “untreatable,” shifting the standard of care for oocyte activation deficiencies. Trial registration number No
Zitieren
APA
Ruso, H., Ahmed-Odia, R., Iliev, D., Popa, T., Rzeznik, Z., He, C., Bailey, M., Karpaviciute, N., Coffey, H., Armas, D. C., AlChami, A., & Hickman, C. (2026). L26/P-249 Overcoming Recurrent Fertilization Failure in Complete Globozoospermia: First Ongoing Pregnancy Using the ICSI SPARK Protocol. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.585
Vancouver
Ruso H, Ahmed-Odia R, Iliev D, Popa T, Rzeznik Z, He C, et al. L26/P-249 Overcoming Recurrent Fertilization Failure in Complete Globozoospermia: First Ongoing Pregnancy Using the ICSI SPARK Protocol. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.585
BibTeX
@article{Ruso2026,
author = {Ruso, H. and Ahmed-Odia, R. and Iliev, D. and Popa, T. and Rzeznik, Z. and He, C. and Bailey, M. and Karpaviciute, N. and Coffey, H. and Armas, D. Cardenas and AlChami, A. and Hickman, C.},
title = {L26/P-249 Overcoming Recurrent Fertilization Failure in Complete Globozoospermia: First Ongoing Pregnancy Using the ICSI SPARK Protocol},
journal = {Human Reproduction},
year = {2026},
volume = {41},
number = {Supplement_1},
doi = {10.1093/humrep/deag083.585}
}
EUVIMED